Beranda › Limfoma Sel-T › Pennsylvania › Philadelphia
Uji klinis Limfoma Sel-T di Philadelphia, PA
10 studi untuk Limfoma Sel-T mencari peserta di lokasi sekitar Philadelphia (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
Menerima pesertaFase 2
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Menerima pesertaStudi observasional
- Children's Hospital of Philadelphia, Philadelphia
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
Menerima pesertaFase 1/2
- University of Pennsylvania, Philadelphia
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
Menerima pesertaFase 3
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23 mi jauhnya
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25 mi jauhnya
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Menerima pesertaFase 1/2
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
CD45BE-HSPC + CART-45 Cells
Menerima pesertaFase 1
- University of Pennsylvania, Philadelphia
Anti-CD7 CAR-T Cells in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoma
Menerima pesertaFase 1
- Children's Hospital of Philadelphia, Philadelphia
A Registry for People With T-cell Lymphoma
Menerima pesertaStudi observasional
- University of Pennsylvania (Data Collection Only), Philadelphia
- Thomas Jefferson University Hospital (Data collection only), Philadelphia
CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL)
Menerima pesertaFase 1
- University of Pennsylvania - Abramson Caner Center, Philadelphia
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Menerima pesertaFase 1
- Children's Hospital of Philadelphia, Philadelphia
Uji klinis Limfoma Sel-T di kota lain
- New York City, NY13 studi
- Baldwin Park, CA9 studi
- Boston, MA9 studi
- Houston, TX8 studi
- Atlanta, GA8 studi
- Rochester, MN6 studi
- Columbus, OH6 studi
- Chicago, IL6 studi
- Seattle, WA6 studi
- New Haven, CT5 studi
- Miami, FL5 studi
- Scottsdale, AZ4 studi
Studi lain di Philadelphia
- Kanker (semua jenis)59 studi
- Kanker Payudara56 studi
- Kanker Paru Non-Sel Kecil51 studi
- Kanker Metastatik46 studi
- Kanker Prostat44 studi
- Kanker Kolorektal44 studi
- Kanker Ovarium44 studi
- Kanker Paru36 studi
- Leukemia Mieloid Akut34 studi
- Gagal Jantung31 studi
- Kanker Endometrium28 studi
- Depresi26 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.